Head of U.S. Pharma Growth & Commercial

Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX:CPHRF); Carmel (IN); On-site; USD 250,000 - 420,000; Full time

Job summary

Cipher Pharmaceuticals is seeking an accomplished U.S. Business Unit Leader to accelerate growth of its US operations, with full P&L responsibility and oversight of sales, marketing, and commercial strategy.

The ideal candidate will drive revenue growth through portfolio expansion, new product acquisitions, and enhanced market execution, building a high-performing, commercially focused organization.

Qualifications

• 10+ years of senior leadership experience in pharma
• Proven success managing full P&L accountability in pharma
• Experience leading multi-functional business units including commercial, ops, finance, and people leadership
• Strong sales leadership with direct oversight of sales teams and field reps
• Experience driving growth through product acquisitions, portfolio expansion, and launches
• MBA or advanced healthcare degrees are assets depending on background

Responsibilities

• Lead U.S. commercial strategy and oversee sales, marketing, and field teams
• Own and manage the full U.S. business unit P&L with accountability for revenue and margin
• Drive growth via product acquisitions, portfolio development, and market expansion
• Build high-performing, commercially focused organization and cross-functional alignment
• Collaborate with global leadership to execute strategic initiatives and performance management

Skills

P&L management

Sales leadership

Strategic planning

Cross-functional leadership

Stakeholder management

Entrepreneurial mindset

Education

Bachelor’s degree

MBA or advanced healthcare degree

Job description

Cipher Pharmaceuticals is seeking an accomplished U.S. Business Unit Leader to accelerate growth of its US operations, with full P&L responsibility and oversight of sales, marketing, and commercial strategy.

The ideal candidate will drive revenue growth through portfolio expansion, new product acquisitions, and enhanced market execution, building a high-performing, commercially focused organization.